PT  - JOURNAL ARTICLE
AU  - Nadine Kaskas
AU  - Joseph F. Merola
AU  - Abrar A. Qureshi
AU  - So Yeon Paek
TI  - Polyphenotypic Psoriasis: A Report from the GRAPPA 2016 Annual Meeting
AID  - 10.3899/jrheum.170149
DP  - 2017 May 01
TA  - The Journal of Rheumatology
PG  - 695--696
VI  - 44
IP  - 5
4099  - http://www.jrheum.org/content/44/5/695.short
4100  - http://www.jrheum.org/content/44/5/695.full
SO  - J Rheumatol2017 May 01; 44
AB  - Recent groundbreaking therapies for psoriasis target specific pathways that drive this systemic inflammatory disease. However, patients with nonplaque psoriasis phenotypes often do not qualify for these therapies and are currently undertreated because of the criteria used during the development of novel agents. We propose use of the phrase “polyphenotypic psoriasis” to describe both plaque and nonplaque subtypes, as well as single and multiple phenotype involvement in individual patients. The goal of using the phrase “polyphenotypic psoriasis” is to remind clinicians about the heterogeneous manifestations of psoriasis in addition to chronic plaque psoriasis.